Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nektar Therapeutics (NASDAQ:NKTR)

24.18
BATS BZX Real-Time Price
As of 3:05pm ET
 +0.19 / +0.79%
Today’s Change
11.41
Today|||52-Week Range
25.02
+97.07%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues148.9M200.7M230.8M165.4M
 
 
 
 
 
Cost of Goods Sold24.2M15.6M21.2M14.9M
 
 
 
 
 
Depreciation And Amortization14.3M12.9M12.9M15.4M
 
 
 
 
 
 
Operating ExpensesGross Income110.4M172.2M196.7M135.2M
 
 
 
 
 
General Expenses219.2M188.7M223.1M248.1M
 
 
 
 
 
Research And Development178.7M147.7M182.8M203.8M
 
 
 
 
 
Total Operating Expenses257.8M217.2M257.2M278.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-108.8M-16.5M-26.4M-112.9M
 
 
 
 
 
Extraordinary Charge-11.3M---17.1M0.00
 
 
 
Interest Expense On Debt40.8M38.8M38.9M42.2M
 
 
 
 
 
Other Expenses392.0K814.0K1.7M2.4M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-159.8M-54.4M-80.7M-152.6M
 
 
 
 
 
Income Taxes-2.2M-512.0K-506.0K-876.0K
 
 
 
 
 
Net Income-162.0M-53.9M-81.2M-153.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS115.7M126.9M132.5M139.6M
 
 
 
 
 
Shares To Calculate EPS Diluted115.7M126.9M132.5M139.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.40-$0.42-$0.61-$1.10
 
 
 
 
 
EPS Diluted-$1.40-$0.42-$0.61-$1.10